Bleeding After Menopause: Why Even Spotting Gets Checked

Bleeding after menopause means any blood, spotting, or pink or brown discharge once you have gone twelve months without a period, and it always needs a doctor. Most causes turn out to be benign, such as a thinned lining or a polyp, but about 9 in 100 cases are endometrial cancer, which is why nobody waits and sees.

This site has spent a long time arguing that symptoms in midlife get waved away too easily. Here the argument runs the other way: no diary to keep, no pattern to wait for.

What counts as bleeding after menopause?

The UK definition is plain. NICE guideline NG12 describes it as unexplained vaginal bleeding more than twelve months after periods have stopped because of the menopause. The NHS page on post-menopausal bleeding spells out how little it takes: spotting, pink or brown discharge, or a small amount of blood, even if it has only happened once. The Cleveland Clinic page says the same, including heavy bleeding and bleeding that happens only once or twice.

The twelve months matter. Bleeding at month ten is still, by definition, perimenopausal, and it restarts the count, which we explain in how long perimenopause actually lasts. Irregular bleeding before that line has its own list of changes worth raising, set out in what a missed period in your forties means. If a coil, the pill or surgery took your periods away before you could count to twelve, the line is blurrier, and recognising the transition without periods covers why. Bleeding that happens after sex while periods are still arriving sits on a different pathway again, which is why bleeding after intercourse in perimenopause is routed through an examination rather than the twelve month clock. The same twelve month line changes what a cramp means too, which is why cramps with no period either side of that line are read one way before it and another way after.

How likely is it to be cancer?

Less likely than the 2am search results suggest, and more likely than the phrase probably just your age implies. The largest pooled estimate is a systematic review and meta-analysis by Clarke and colleagues in JAMA Internal Medicine, 2018, covering 129 studies and 40,790 patients. It found that 9% of women with postmenopausal bleeding were diagnosed with endometrial cancer, with a 95% confidence interval of 8% to 11%.

The same review ran the numbers the other way, and this is the half that explains the firm guidance: 91% of women with endometrial cancer had postmenopausal bleeding. Bleeding is not a reliable sign of cancer, but it is the sign almost everyone with this cancer gets, and it tends to show up early. The risk figure also moved around. It ranged from 7% to 12% depending on hormone therapy use, and from 5% in North American studies to 13% in Western European ones. The one in ten figure quoted elsewhere is a fair rounding, not a constant of nature.

What usually causes it instead?

Most of the time, something benign. The StatPearls review on postmenopausal bleeding, updated in June 2026, names genitourinary atrophy, a thinning of those tissues, as the most common cause, at around 60%, with endometrial polyps another frequent finding. The NHS lists a thinned vaginal lining, cervical polyps and a thickened womb lining, and less often cancer of the womb or ovary. Ovarian cancer more often shows itself through bloating, fullness, pain and urinary change than through bleeding, and the pattern of ovarian cancer symptoms that prompts testing is about how often and how new they are. Other causes include fibroids, inflammation of the cervix, and bleeding that turns out to come from the bladder or bowel.

Hospital studies report quite different mixes of causes depending on who was referred, so treat any single breakdown as rough. What no source disputes is that nobody can tell which cause applies without an examination and tests. That includes the reader, and it includes this article.

What happens at the appointment, and did the guidance just change?

It did, in the United States, and most of the pages ranking for this search have not caught up. For years the American College of Obstetricians and Gynecologists 2018 committee opinion allowed a transvaginal ultrasound as a reasonable first test, because a womb lining of 4 mm or less has a greater than 99% negative predictive value for endometrial cancer. In April 2026 ACOG published updated guidance in Obstetrics and Gynecology recommending both an ultrasound and an endometrial biopsy for most people.

As summarised in Cleveland Clinic’s clinical coverage of the update, ultrasound alone is now reserved for someone with a single episode of bleeding, a fully visible lining of 4 mm or less, no strong risk factors, and access to prompt follow up. The reasons given include polyps and fibroids that a scan can miss, aggressive cancer types for which lining thickness is a poor guide, and a reported false negative probability of about 10% for ultrasound in Black women. Here is how the main sources line up, checked on 13 September 2026.

Source	What it says to do	Version read
NICE NG12, recommendations 1.5.10 and 1.5.11	Aged 55 and over: refer on a suspected cancer pathway. Under 55: consider that referral	January 2026 text
ACOG updated guidance	Ultrasound plus biopsy for most. Ultrasound alone only in a narrow group, and never for repeat episodes	April 2026
ACOG committee opinion 734	Ultrasound is a reasonable first test; lining of 4 mm or less rarely cancer	May 2018, now superseded in part
NHS post-menopausal bleeding page	See a GP even if it happened once. Tests may include scan, hysteroscopy, biopsy	Reviewed May 2023
Cleveland Clinic patient page	Always see a provider. Lists ultrasound and biopsy without saying who needs which	Reviewed January 2024

Which tests fit a particular person is a clinical decision. What the table does show is why a friend’s experience from a few years ago may not match what happens now.

How quickly should you be seen?

Without delay. Book the appointment when it happens, even if the bleeding has stopped and even if it was only a spot. In the UK, NICE says women aged 55 and over with postmenopausal bleeding should be referred on a suspected cancer pathway, the route many people still call the two week wait, and that it should be considered under 55. The US sources read here set no fixed timeline.

If you are using HRT, bleeding still gets reported rather than explained away at home. StatPearls notes that hormone therapy frequently causes bleeding in the first two to three months after starting and that this settles for most women, but that judgement belongs to the prescriber. The January 2026 NG12 text this article read carries no separate HRT wording in those two recommendations. A secondary summary reports that an April 2026 review added a note that bleeding on HRT still needs a clinical judgement about whether HRT genuinely explains it; we could not read that version at NICE, so treat that detail as unconfirmed.

What do people who have been through the checks report?

Guidance says what should happen. Patient threads show what did. This article read two public threads in full in the r/Menopause community, both posted around June 2026 and carrying roughly 115 comments between them, including about forty people describing the outcome of their own investigations. These are accounts, not evidence, and people who join a menopause forum are not a random sample of anyone.

In a thread asking what happened after postmenopausal bleeding, most outcomes described were benign: polyps, fibroids, adenomyosis, or nothing found at all. One commenter described endometrial cancer treated about three years earlier and doing well since. Two described precancerous changes found on biopsy and treated with a hysterectomy. One of those two said her spotting was so light she would never have phoned about it; she only mentioned it at a routine check, was sent for a scan and biopsy, and had surgery in April 2026.

Speed varied more than any guideline would suggest. A UK commenter described going onto the urgent pathway, having a scan, a hysteroscopy and a biopsy, and being given the all clear two weeks to the day after her first appointment. Another said her GP marked it urgent, yet it took five months and a private referral to see a gynaecologist, and seven months before she was examined. A Canadian commenter described waiting six months for an ultrasound. At the other end, one woman in her sixties described two years of brown spotting through two scans, a biopsy and a hysteroscopy that removed a benign polyp, and still no answer.

The second thread was about pain. Its author, bleeding on HRT with a normal lining on ultrasound, was offered an in office biopsy and hysteroscopy without sedation, or a wait of at least two months for sedation. The replies ranged widely. Several described office biopsies or hysteroscopies as severely painful and said they would not repeat one without pain relief. Others said it was uncomfortable but quick, one likening each sample to an injection lasting about a second.

Where the accounts agree with the guidance: benign causes dominated, and repeat bleeding after a clear first result led to further tests, which is exactly what the 2026 ACOG update describes. Where they part company: the guidance pages this article read say little about how long the wait may be, and none of them mention asking what pain relief is available for an office procedure, which was the single most common worry in both threads. No account here says anything about what any other person’s bleeding is.

What if the tests are clear and it happens again?

It gets reported again. The ACOG update states that the option of skipping a biopsy does not apply to anyone with more than one episode of bleeding, and the NHS advice does not come with a limit on how many times it applies. A clear result describes the day it was done. We have written about the other changes that continue after menopause, and bleeding is the one on that list that is never filed under ordinary.

Frequently asked questions

---

This article is general information, not medical advice, and is not a substitute for care from a qualified healthcare professional. Speak to your doctor about your own situation.